Program Type
Disease
Project Status

Displaying 1 - 25 of 99

Stephen E. Straus Distinguished Lecture
TRUST: Gene and Protein Expression Biomarkers for Frequent Gout Flaring
This project’s objective is to build a predictive multi-omics model for gout flares....
RECOVER-TLC Will Advance Long COVID Research
RECOVER-TLC unites the scientific and patient community in finding new approaches to address Long COVID. This FNIH program is led by NIAID....
The Kovler Prize for Trust in Life Science Journalism
The Kovler Prize for Trust in Life Science Journalism honors an individual who has significantly increased the public’s awareness and unde...
AMP Parkinson’s Disease and Related Disorders
AMP Parkinson’s Disease and Related Disorders (AMP PDRD) builds on the infrastructure established during AMP Parkinson’s Disease (AMP PD...
Joint FDA/FNIH Workshop for Digital Measures
FNIH conducted a joint FDA/FNIH workshop for Digital Measures that brought together industry leaders, regulatory bodies, researchers, and pa...
AMP Amyotrophic Lateral Sclerosis
The Accelerating Medicines Partnership® (AMP®) Amyotrophic Lateral Sclerosis (AMP ALS) is accelerating therapeutic and biomarker developme...
Team Science Day 2024
MMyeRisk: Defining Tumor and Immune Markers to Stratify Patients at Risk of Developing Multiple Myeloma from MGUS and Smoldering Myeloma
AMP Symposium
February 5-6, 2024 – North Bethesda, MD The Accelerating Medicines Partnership® (AMP®) Program was launched in February 2014 to bring t...
Cognitive Aging Summit IV
Biomarkers Consortium – Biomarkers for Risk Stratification and Detection of Early-Onset Preeclampsia
iRelate: Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
Convening Experts in Oncology to Address Children’s Health (COACH)
Targeted Gene Delivery for Sickle Cell Disease
Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE)
Biomarkers Consortium – Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers
The ACTIV Tracking Resistance and Coronavirus Evolution (TRACE) Working Group
The Problem Mutations in SARS-CoV-2 are occurring, and some that are reaching high frequency could reduce therapeutic or vaccine efficacy. ...
The Biomedical Research Community Responds to the Opioids Crisis
Overview Opioid addiction, misuse and overdose is an ongoing and rapidly evolving public health crisis. According to the Centers for Diseas...
The Charles A. Sanders Legacy Fund: Honoring Decades of Inspired Leadership, Supporting Novel, Transformative Science
  Honoring Decades of Inspired Leadership The Charles A. Sanders Legacy Fund was established by the Foundation for the Nation...
The Dr. Franklin A. Neva Memorial Fund
Overview The Dr. Franklin A. Neva Memorial Fund honors the legacy of Franklin A. Neva, M.D., a renowned virologist, parasitologist, clinici...
The NIH Undiagnosed Diseases Program
Overview The NIH Undiagnosed Diseases Program (UDP) is part of the Undiagnosed Disease Network, an NIH Common Fund initiative that focuses ...
The Pew Scholars and Fellows Program in the Biomedical Sciences
Overview The Pew Biomedical Scholars Program provides funding to young investigators of outstanding promise in science relevant to the adva...
Understanding the Mechanisms of Intravenous BCG-Induced Protection Against Tuberculosis in Nonhuman Primates (TB Vaccine)
The Problem Only one vaccine (the BCG vaccine) protects infants against tuberculosis (TB) – the deadliest infection in the world – but ...
The Judy and Peter Blum Kovler Foundation Intramural Fellow
In 2021, The Judy and Peter Blum Kovler Foundation, working with the Foundation for the National Institutes of Health (FNIH), established a ...

Diseases

Partner With Us